Nasal Septum, IrregularNCT06884592
Determination of the Frequency and Predictors of Difficult Intubation in Septoplasty Operations
An observational study of Nasal Septum, Irregular and Nasal Septal Defect, run by Başakşehir Çam & Sakura City Hospital at 1 site in Turkey (Türkiye).
Trial summary
Deviated septum is among the most prevalent etiologies of nasal obstruction. Congenital or acquired deformities of the nasal septum have been demonstrated to result in partial obstruction of the airflow, thereby causing respiratory distress. Read more about this study
- Who is it for?
- Ages 18 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Nasal Septum, Irregular, Nasal Septal Defect, Difficult Airway
- What is being tested?
- Difficult Intubation
- Type of treatment
- Injection or infusion, Surgery or procedure
- How many people
- 330 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 28 May 2025to 28 Sep 2026
- How long will I take part?
- 2 Days
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Patients with nasal congestion due to deviated nasal septum who will undergo septoplasty surgery under general anaesthesia
Who may be able to join
- Consenting patients,
- ASA-I-II
- Between the ages of 18 and 65,
- Difficult intubation and no history of facial trauma or congenital craniofacial deformity
- Patients with easy mask ventilation during the procedure
- Nasal obstruction due to deviated nasal septum,
- Patients who will receive general anaesthesia and undergo septoplasty surgery
Who cannot join
- Patients without consent
- Not in the appropriate age range,
- Patients who do not receive general anaesthesia and will not undergo septoplasty surgery,
- ASA-IV-V with ,
- Difficult intubation and a history of facial trauma or congenital craniofacial deformity
- Patients with easy mask ventilation during the procedure
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Başakşehir Çam and Sakura City Hospital
Başakşehir, Istanbul, 34480
About this study
Official title: Determination of the Incidence of Difficult Intubation and Predictive Factors in Patients Undergoing Nasal Septum Deviation Surgery.
Deviated septum is among the most prevalent etiologies of nasal obstruction. Congenital or acquired deformities of the nasal septum have been demonstrated to result in partial obstruction of the airflow, thereby causing respiratory distress. Furthermore, studies have indicated a potential correlation between nasal congestion and Obstructive Sleep Apnoea Syndrome (OSAS). It is a well-documented phenomenon that patients suffering from nasal obstruction often exhibit an open mouth during sleep, a condition that has been shown to result in the narrowing of the pharyngeal lumen and the subsequent development of sleep-related breathing disorders, including snoring and sleep apnoea. Surgical intervention to correct a deviated nasal septum (commonly referred to as septoplasty) has been shown to reduce upper airway resistance by enhancing airflow, leading to a reduction in the severity of both snoring and OSAS. Numerous studies have demonstrated a robust correlation between a deviated nasal septum and asymmetric facial growth, including maxillary and mandibular abnormalities. While septoplasty is considered a minor surgical procedure with a low anaesthetic risk, concomitant obstructive sleep apnoea syndrome (OSAS) and facial asymmetry have been demonstrated to be associated with an increased risk of difficult intubation. Consequently, the development of preoperative assessment tests to predict difficult intubation is imperative for effective planning of the necessary preoperative preparation when such complications are anticipated. The present study therefore sought to evaluate the incidence of difficult airway in patients undergoing septoplasty. The secondary aim was to determine the predictive factors associated with difficult airway in patients undergoing septoplasty.
Read the detailed description
Although septoplasty is a minor surgery with low anaesthetic risk, it is a surgical group in which unpredictable difficult airway is frequently encountered due to anatomical facial deformities in patients. To the best of our knowledge, there are no studies on the incidence of difficult airway and predictive factors associated with difficult airway in septoplasty operations. The objectives of this study are threefold: firstly, to determine the incidence of difficult airway in patients undergoing septoplasty surgery; secondly, to ascertain the predictive factors associated with difficult airway in preoperative evaluation; and thirdly, to reduce the complications that may arise from difficult intubation and ensure patient safety by making the necessary difficult airway preparations in the preoperative period in a timely manner. It is anticipated that the study will not engender any additional risks, as no supplementary interventions or medications will be administered to patients beyond those customary to them.
The prospective cohort (observational) study will include American Society of Anesthesiologists (ASA) I and II patients (aged 18-65 years) with an indication for septoplasty under general anaesthesia (requiring tracheal intubation) due to nasal obstruction caused by nasal septum deviation. Patients with a history of difficult intubation and facial trauma or congenital craniofacial deformity, and patients with difficult mask ventilation during the procedure, will be excluded from this study. Preoperative airway assessment will be performed in all patients using the LEMON protocol for difficult airway prediction. The STOP-BANG questionnaire will be administered to all patients in order to determine the risk of OSAS. The upper lip bite test, a component of the preoperative difficult airway assessment, will be employed.Standard monitoring, encompassing electrocardiography (ECG), noninvasive blood pressure, and peripheral oxygen saturation (SpO2), will be conducted. The induction of anaesthesia will be standardised, comprising midazolam at 0.05 mg kg-1, propofol at 2-3 mg kg-1, fentanyl at 1.5 µg kg-1, and rocuronium at 0.6-1 mg kg-1. Mechanical ventilation will be facilitated using a face mask with 100% oxygen. The use of an oropharyngeal airway will be considered if deemed necessary. Neuromuscular function monitoring is a technique that involves electrical stimulation of a motor nerve and monitoring the response of the muscle innervated by this nerve. This monitoring technique may be employed subsequent to neuromuscular blockade. Importantly, it is used to confirm the adequacy of relaxation after administration of neuromuscular blocking agents.The ratio is monitored, and intubation will be performed at TOF: 0/4. For male patients, Macintosh blades number 3 will be used, and for female patients, Macintosh blades number 4 will be used. All intubation procedures will be performed by an anaesthesiologist specialised in the ENT department. Cormack-Lehane laryngeal appearance grades will be noted during laryngoscopy. The Cormack-Lehane scale will be used to determine the difficulty of intubation as follows: grade I or II will be considered easy, and grade III or IV will be considered difficult. If intubation could not be performed with the Macintosh laryngoscope in three attempts, the subsequent steps would be to perform intubation with the videolaryngoscope and then to place the Laryngeal Mask Airway (LMA). The correct position of the tube in the trachea will be confirmed post-intubation, preferably by visual confirmation of the tube passing through the glottic opening, auscultation of the chest with a stethoscope and a normal capnograph. In the event of failure of the LMA attempt, the patient will be permitted to awaken, with the final step being ventilation using a face mask and consideration of reversing the muscle relaxant effect with sugammadex (4-5 mg/kg). In the event of intubation failure on the first attempt, the use of an intubation stylet will be considered if deemed necessary. The intubation method employed, the total number of attempts for successful intubation, stylet use, optimal external laryngeal manipulation application (cricoid pressure) and oropharyngeal airway placement during face mask ventilation will be recorded. The analysis of these values will contribute to the identification of the incidence of difficult airway in patients with deviated nasal septum and the identification of the most common predictive parameter.
- Conditions
- Nasal Septum, Irregular, Nasal Septal Defect, Difficult Airway, Difficult Endotracheal Intubation, Predicted Difficult Airway
- Being tested
- Difficult Intubation
- Keywords
- Septoplasty, Nasal Septum Deviation, Difficult Airway, Predicted Difficult Airway
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Difficult IntubationProcedure or surgery
Also called Predicted Difficult Airway
Determination of difficult intubation, according to the Cormack-Lehane scale, intubation will be considered easy for grade I or II and difficult for grade III or IV. If intubation could not be performed with the Macintosh laryngoscope in three attempts, the next step would be to perform intubation with the videolaryngoscope and the third step would be to place the laryngeal mask airway (LMA). The correct position of the tube in the trachea will be confirmed after intubation, preferably by visual confirmation of the tube passing through the glottic opening, auscultation of the chest with a stethoscope and a normal capnograph. If the LMA attempt fails, the patient will be allowed to awaken, with the final step being ventilation using a face mask and consideration of reversing the muscle relaxant effect with sugammadex (4-5 mg/kg). If intubation fails on the first attempt, an intubation stylet will be used if necessary. The intubation method used, total number of attempts for successful i
| Study group | Role | What they receive |
|---|---|---|
| Difficult Airway in Septoplasty | The American Society of Anesthesiologists (ASA) I and II patients (aged 18-65 years) with a medical indication for septoplasty under general anaesthesia (requiring tracheal intubation) due to nasal obstruction caused by a deviated nasal septum. Receives: Procedure: Difficult Intubation |
What is being measured
The primary outcome is the main question the study is designed to answer.
Cormack-Lehane laryngeal view scale
The anaesthesiologist's assessment is based on the laryngoscopic view of Cormack-Lehane. The Cormack- Lehane test categorises the following grades:
Grade I: Entire glottis is visible; Grade II: Glottis partially visible; Grade III: Only the epiglottis is visible; Grade IV: Epiglottis also not visible Grade III and IV are considered difficult intubation.
Measured: 3 interventions during procedure
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Mar 2025
- Study start28 May 2025
- Primary completion15 Sep 2026
- Study completion28 Sep 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (4)Papers the sponsor has linked to this study.
- Other trials for Nasal Septum, IrregularStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 330 participants (actual)
- Target duration
- 2 Days
Sponsor and investigators
- Lead sponsor
- Başakşehir Çam & Sakura City Hospital
- Sponsor type
- Other government
- Responsible party
- Principal investigator, Emine OZCAN, Başakşehir Çam & Sakura City Hospital
- Investigators
- EMINE OZCAN, Anesthesiologist, Principal investigator, Başakşehir Çam ve Sakura Şehir HastanesiHILAL AKÇA, Anesthesiologist, Study chair, Başakşehir Çam ve Sakura Şehir Hastanesi
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06884592
- Sponsor's protocol ID
- NSD2025
- Status last verified
- Sep 2026
- First submitted
- 13 Mar 2025
- Last updated
- 5 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: All IPD underlying the results in a publication
Publications
Demet Altun, Achmet Ali, Levent Aydemir, Nil Kırşan, Mukadder Orhan Sungur, Emre Çamcı Determination of the Difficult Intubation Incidence and its Affecting Factors in Patients Undergoing Septal Deviation Surgery Prospective Controlled Trial DOI:10.14744/scie.2019.55477 South.Clin.Ist. Euras.2020;31(1):1-7
Dr.Neha Sharma, Dr.Suman Shekhar Tiwari, Dr.Anurag Srivastava, Dr.Prakriti Gupta The preoperative evaluation of risk variables associated with difficult intubation International Journal of Life Sciences Biotechnology and Pharma Research Vol. 12, No. 2, April- June 2023 ISSN: 2250-3137
Karakus O, Kaya C, Ustun FE, Koksal E, Ustun YB. [Predictive value of preoperative tests in estimating difficult intubation in patients who underwent direct laryngoscopy in ear, nose, and throat surgery]. Rev Bras Anestesiol. 2015 Mar-Apr;65(2):85-91. doi: 10.1016/j.bjan.2014.05.011. Epub 2014 Nov 28. Portuguese.
PubMed 25435415Mathangi K, Mathews J, Mathangi CD. Assessment of perioperative difficult airway among undiagnosed obstructive sleep apnoea patients undergoing elective surgery: A prospective cohort study. Indian J Anaesth. 2018 Jul;62(7):538-544. doi: 10.4103/ija.IJA_158_18.
PubMed 30078857
Study at a glance
From the registry record, last updated by the sponsor on 5 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Determination of the Incidence of Difficult Intubation and Predictive Factors in Patients Undergoing Nasal Septum Deviation Surgery.
- ClinicalTrials.gov ID
- NCT06884592
- Acronym / sponsor ID
- NSD2025
- Conditions
- Nasal Septum, Irregular, Nasal Septal Defect, Difficult Airway, Difficult Endotracheal Intubation, Predicted Difficult Airway
- Keywords
- Septoplasty, Nasal Septum Deviation, Difficult Airway, Predicted Difficult Airway
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 330 participants (actual)
- Lead sponsor
- Başakşehir Çam & Sakura City HospitalOther government
- Study start
- 28 May 2025 (actual)
- Primary completion
- 15 Sep 2026 (actual)
- Study completion
- 28 Sep 2026 (actual)
- First posted
- 19 Mar 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Deviated septum is among the most prevalent etiologies of nasal obstruction. Congenital or acquired deformities of the nasal septum have been demonstrated to result in partial obstruction of the airflow, thereby causing respiratory distress. Furthermore, studies have indicated a potential correlation between nasal congestion and Obstructive Sleep Apnoea Syndrome (OSAS). It is a well-documented phenomenon that patients suffering from nasal obstruction often exhibit an open mouth during sleep, a condition that has been shown to result in the narrowing of the pharyngeal lumen and the subsequent development of sleep-related breathing disorders, including snoring and sleep apnoea. Surgical intervention to correct a deviated nasal septum (commonly referred to as septoplasty) has been shown to reduce upper airway resistance by enhancing airflow, leading to a reduction in the severity of both snoring and OSAS. Numerous studies have demonstrated a robust correlation between a deviated nasal septum and asymmetric facial growth, including maxillary and mandibular abnormalities. While septoplasty is considered a minor surgical procedure with a low anaesthetic risk, concomitant obstructive sleep apnoea syndrome (OSAS) and facial asymmetry have been demonstrated to be associated with an increased risk of difficult intubation. Consequently, the development of preoperative assessment tests to predict difficult intubation is imperative for effective planning of the necessary preoperative preparation when such complications are anticipated. The present study therefore sought to evaluate the incidence of difficult airway in patients undergoing septoplasty. The secondary aim was to determine the predictive factors associated with difficult airway in patients undergoing septoplasty.
Detailed description
Although septoplasty is a minor surgery with low anaesthetic risk, it is a surgical group in which unpredictable difficult airway is frequently encountered due to anatomical facial deformities in patients. To the best of our knowledge, there are no studies on the incidence of difficult airway and predictive factors associated with difficult airway in septoplasty operations. The objectives of this study are threefold: firstly, to determine the incidence of difficult airway in patients undergoing septoplasty surgery; secondly, to ascertain the predictive factors associated with difficult airway in preoperative evaluation; and thirdly, to reduce the complications that may arise from difficult intubation and ensure patient safety by making the necessary difficult airway preparations in the preoperative period in a timely manner. It is anticipated that the study will not engender any additional risks, as no supplementary interventions or medications will be administered to patients beyond those customary to them.
The prospective cohort (observational) study will include American Society of Anesthesiologists (ASA) I and II patients (aged 18-65 years) with an indication for septoplasty under general anaesthesia (requiring tracheal intubation) due to nasal obstruction caused by nasal septum deviation. Patients with a history of difficult intubation and facial trauma or congenital craniofacial deformity, and patients with difficult mask ventilation during the procedure, will be excluded from this study. Preoperative airway assessment will be performed in all patients using the LEMON protocol for difficult airway prediction. The STOP-BANG questionnaire will be administered to all patients in order to determine the risk of OSAS. The upper lip bite test, a component of the preoperative difficult airway assessment, will be employed.Standard monitoring, encompassing electrocardiography (ECG), noninvasive blood pressure, and peripheral oxygen saturation (SpO2), will be conducted. The induction of anaesthesia will be standardised, comprising midazolam at 0.05 mg kg-1, propofol at 2-3 mg kg-1, fentanyl at 1.5 µg kg-1, and rocuronium at 0.6-1 mg kg-1. Mechanical ventilation will be facilitated using a face mask with 100% oxygen. The use of an oropharyngeal airway will be considered if deemed necessary. Neuromuscular function monitoring is a technique that involves electrical stimulation of a motor nerve and monitoring the response of the muscle innervated by this nerve. This monitoring technique may be employed subsequent to neuromuscular blockade. Importantly, it is used to confirm the adequacy of relaxation after administration of neuromuscular blocking agents.The ratio is monitored, and intubation will be performed at TOF: 0/4. For male patients, Macintosh blades number 3 will be used, and for female patients, Macintosh blades number 4 will be used. All intubation procedures will be performed by an anaesthesiologist specialised in the ENT department. Cormack-Lehane laryngeal appearance grades will be noted during laryngoscopy. The Cormack-Lehane scale will be used to determine the difficulty of intubation as follows: grade I or II will be considered easy, and grade III or IV will be considered difficult. If intubation could not be performed with the Macintosh laryngoscope in three attempts, the subsequent steps would be to perform intubation with the videolaryngoscope and then to place the Laryngeal Mask Airway (LMA). The correct position of the tube in the trachea will be confirmed post-intubation, preferably by visual confirmation of the tube passing through the glottic opening, auscultation of the chest with a stethoscope and a normal capnograph. In the event of failure of the LMA attempt, the patient will be permitted to awaken, with the final step being ventilation using a face mask and consideration of reversing the muscle relaxant effect with sugammadex (4-5 mg/kg). In the event of intubation failure on the first attempt, the use of an intubation stylet will be considered if deemed necessary. The intubation method employed, the total number of attempts for successful intubation, stylet use, optimal external laryngeal manipulation application (cricoid pressure) and oropharyngeal airway placement during face mask ventilation will be recorded. The analysis of these values will contribute to the identification of the incidence of difficult airway in patients with deviated nasal septum and the identification of the most common predictive parameter.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 2 Days
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Difficult Airway in Septoplasty | – | Procedure: Difficult IntubationThe American Society of Anesthesiologists (ASA) I and II patients (aged 18-65 years) with a medical indication for septoplasty under general anaesthesia (requiring tracheal intubation) due to nasal obstruction caused by a deviated nasal septum. |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Patients with nasal congestion due to deviated nasal septum who will undergo septoplasty surgery under general anaesthesia
Key inclusion criteria (7 listed)
- Consenting patients,
- ASA-I-II
- Between the ages of 18 and 65,
- Difficult intubation and no history of facial trauma or congenital craniofacial deformity
- Patients with easy mask ventilation during the procedure
Key exclusion criteria (6 listed)
- Patients without consent
- Not in the appropriate age range,
- Patients who do not receive general anaesthesia and will not undergo septoplasty surgery,
- ASA-IV-V with ,
- Difficult intubation and a history of facial trauma or congenital craniofacial deformity
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Difficult IntubationAlso: Predicted Difficult AirwayDetermination of difficult intubation, according to the Cormack-Lehane scale, intubation will be considered easy for grade I or II and difficult for grade III or IV. If intubation could not be performed with the Macintosh laryngoscope in three attempts, the next step would be to perform intubation with the videolaryngoscope and the third step would be to place the laryngeal mask airway (LMA). The correct position of the tube in the trachea will be confirmed after intubation, preferably by visual confirmation of the tube passing through the glottic opening, auscultation of the chest with a stethoscope and a normal capnograph. If the LMA attempt fails, the patient will be allowed to awaken, with the final step being ventilation using a face mask and consideration of reversing the muscle relaxant effect with sugammadex (4-5 mg/kg). If intubation fails on the first attempt, an intubation stylet will be used if necessary. The intubation method used, total number of attempts for successful i | Procedure or surgery | Difficult Airway in Septoplasty |
Primary outcome
Cormack-Lehane laryngeal view scale
Time frame: 3 interventions during procedure
The anaesthesiologist's assessment is based on the laryngoscopic view of Cormack-Lehane. The Cormack- Lehane test categorises the following grades: Grade I: Entire glottis is visible; Grade II: Glottis partially visible; Grade III: Only the epiglottis is visible; Grade IV: Epiglottis also not visible Grade III and IV are considered difficult intubation.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Oct 2026.
- BackgroundDemet Altun, Achmet Ali, Levent Aydemir, Nil Kırşan, Mukadder Orhan Sungur, Emre Çamcı Determination of the Difficult Intubation Incidence and its Affecting Factors in Patients Undergoing Septal Deviation Surgery Prospective Controlled Trial DOI:10.14744/scie.2019.55477 South.Clin.Ist. Euras.2020;31(1):1-7
- BackgroundDr.Neha Sharma, Dr.Suman Shekhar Tiwari, Dr.Anurag Srivastava, Dr.Prakriti Gupta The preoperative evaluation of risk variables associated with difficult intubation International Journal of Life Sciences Biotechnology and Pharma Research Vol. 12, No. 2, April- June 2023 ISSN: 2250-3137
- Background: PubMed 25435415Karakus O, Kaya C, Ustun FE, Koksal E, Ustun YB. [Predictive value of preoperative tests in estimating difficult intubation in patients who underwent direct laryngoscopy in ear, nose, and throat surgery]. Rev Bras Anestesiol. 2015 Mar-Apr;65(2):85-91. doi: 10.1016/j.bjan.2014.05.011. Epub 2014 Nov 28. Portuguese.
- Background: PubMed 30078857Mathangi K, Mathews J, Mathangi CD. Assessment of perioperative difficult airway among undiagnosed obstructive sleep apnoea patients undergoing elective surgery: A prospective cohort study. Indian J Anaesth. 2018 Jul;62(7):538-544. doi: 10.4103/ija.IJA_158_18.
- The National Center for Biotechnology Information advances science and health by providing access to biomedical and genomic information. And Southern Clinics of Istanbul EurasiaLink provided by the sponsor.
- Individual participant dataSharing planned: Yes. All IPD underlying the results in a publication
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
EMINE OZCAN, Anesthesiologist principal investigator
Başakşehir Çam ve Sakura Şehir Hastanesi
HILAL AKÇA, Anesthesiologist study chair
Başakşehir Çam ve Sakura Şehir Hastanesi
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Nasal Septum, Irregular and Nasal Septal Defect, run by Başakşehir Çam & Sakura City Hospital at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 5 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Cormack-Lehane laryngeal view scale (time frame: 3 interventions during procedure). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06884592, which also lists 4 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Oct 2026.